Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Can a K103N HIV strain stably overcome the wild type in the absence of non-nucleoside reverse transcriptase inhibitor selective pressure?

AIDS (London, England) - 24 Mar 2005

Capetti Amedeo F, Gabris Alexandra I, Drago Lorenzo, Vigevani Gian Marco

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Drug Resistance, Viral
Share to HIV-1
Share to HIV Infections

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Mutation

Share to Reverse Transcriptase Inhibitors

Share to Selection, Genetic

Source

Identifiers

PMID: 15802985
DOI: 10.1097/01.aids.0000163943.31682.c8

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Can a K103N HIV strain stably overcome the wild type in the absence of non-nucleoside reverse transcriptase inhibitor selective pressure?PMID 15802985Read ↗

[Molecular mechanisms for the emergence of drug-resistant HIV-1].Semantic proximity Read ↗

A unique, naturally occurring single-amino acid mutation in HIV type 1 V3 loop can discriminate between its cytopathicity and replication in vivo and in vitro.Semantic proximity Read ↗

Defying death--HIV mutation to evade cytotoxic T lymphocytes.Semantic proximity Read ↗

Transmission network of an HIV type 1 strain with K103N in young Belgian patients from different risk groups.Semantic proximity Read ↗

Structural basis of drug resistance for the V82A mutant of HIV-1 proteinaseSemantic proximity Read ↗

In vivo dynamics of the 103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in HIV-infected patients: preliminary results.Semantic proximity Read ↗

Touching the heart of HIV-1 drug resistance: the fingers close down on the dNTP at the polymerase active siteSemantic proximity Read ↗

Selective-advantage profile of human immunodeficiency virus type 1 integrase mutants explains in vivo evolution of raltegravir resistance genotypes.Semantic proximity Read ↗

In vivo dynamics of the K103N mutation following the withdrawal of non-nucleoside reverse transcriptase inhibitors in Human Immunodeficiency Virus-infected patients.Semantic proximity Read ↗

Evolution of a novel 5-amino-acid insertion in the beta3-beta4 loop of HIV-1 reverse transcriptase.Semantic proximity Read ↗

Mutations at 65 and 70 within the context of a Q151M cluster in human immunodeficiency virus type 1 reverse transcriptase impact the susceptibility to the different nucleoside reverse transcriptase inhibitors in distinct ways.Semantic proximity Read ↗

Which nucleoside and nucleotide backbone combinations select for the K65R mutation in HIV-1 reverse transcriptase.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.